HIT Consultant August 23, 2024
Syed Hamza Sohail

What You Should Know:

Qure.ai, a global innovator in medical imaging AI, has today announced a pivotal 510(k) FDA clearance for its AI-powered chest CT solution – qCT LN Quant.

– The new AI solution is now available to support radiologists and pulmonologists in analyzing lung nodules on non-contrast chest CT scans and tracking volumetric growth as part of progression monitoring.

Qure.ai Enhances Lung Cancer Care with AI-Powered qCT LN Quant

Qure.ai has integrated qCT LN Quant into its AI-powered lung cancer care continuum in the US, providing comprehensive solutions to identify, measure, manage, and monitor lung health. These tools support clinicians in healthcare institutions, driving early detection and improving patient outcomes.

Key components of Qure.ai’s lung health solutions...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: AI (Artificial Intelligence), FDA, Govt Agencies, Provider, Radiology, Technology
Building An AI-Centric Organization In 2025
High-Performance Computing in the AI Era: Challenges and Future Prospects
The Transformative Power Of AI And Machine Learning On Healthcare Insurance
How rural hospitals, Silicon Valley can head off the AI digital divide
Enhancing primary care: The impact of pharmacist-led chronic care and AI-driven telehealth

Share This Article